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CONSUMER KNOWLEDGE AND BELIEFS REGARDING ANTIBIOTIC 
RESISTANCE: A TELEPHONE SURVEY AND FOCUS GROUP INTERVIEW
Chae SM, Park S, Park EJ
Korea Institute for Health and Social Affairs, Seoul, Seoul, South Korea
OBJECTIVES: This study was performed to examine knowledge and attitudes regard-
ing antibiotic resistance. METHODS: We conducted both quantitative study 
and qualitative study. For a quantitative study, a cross-sectional telephone survey 
was conducted in 2009 on 1015 persons aged 20 or older. The questionnaires con-
sisted of consumer knowledge, attitudes and beliefs about antibiotic resistance. For a 
qualitative study, we asked similar questions to the 9 participants. RESULTS: In the 
telephone survey, 75.9% of respondents agreed that antibiotic resistance means that 
a microorganism has the ability of withstanding the effects of antibiotics. Perception 
of antibiotic resistance was signiﬁcantly different according to education, household 
income. The respondents who had better education and higher household income 
responded they knew well about antibiotic resistance. All of the FGI participants have 
ever heard about antibiotic resistance, but they didn’t understand that exactly. They 
described antibiotic resistance as body becoming immune or resistant to antibiotics 
through antibiotic use. They also thought that antibiotic resistance would not inﬂuence 
their health because they were healthy and did not take antibiotics much. CONCLU-
SIONS: Most respondents were aware of antibiotic resistance. However, when we 
conducted FGI, we found there was some confusion among participants about the 
meaning of antibiotic resistance. Because incorrect knowledge for antibiotic resistance 
may lead to inappropriate health behavior such as low compliance with antibiotics, 
further public education and publicity program is needed.
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PREVALENCE AND PREDICTORS OF UNINTENTIONAL NON-
ADHERENCE AMONG ADULTS WITH CHRONIC DISEASE WHO 
SELF-IDENTIFY AS BEING ADHERENT TO PRESCRIPTION 
MEDICATIONS
Gadkari A, McHorney C
Merck & Co., Inc., North Wales, PA, USA
OBJECTIVES: Unintentional non-adherence has been characterized as passively 
inconsistent medication-taking behavior (negligence, carelessness, or forgetfulness). 
Our objective was to study the prevalence and predictors of unintentional non-
adherence. METHODS: We conducted a cross-sectional survey of adults with asthma, 
hypertension, diabetes, hyperlipidemia, osteoporosis, or depression from the Harris 
Chronic Disease Panel. A total of 24,071 adults self-identiﬁed themselves as adherent 
to prescription medications for their index disease and answered three questions on 
unintentional non-adherence: During the past six months, did you 1) ever forget to 
take the medication; 2) run out of the medication; and 3) were careless at times about 
taking the medication? Logistic regression was used to model predictors of each 
unintentional non-adherence behavior. Independent variables were demographics, 
index chronic disease, total number of prescription medications, self-rated health, and 
multi-item scales assessing perceived need for medications, medication concerns, and 
perceived medication affordability. RESULTS: For the index disease: 62% forgot to 
take a medication, 37% had run out of the medication, and 23% were careless about 
taking the medication. Common multivariate predictors (p < .001) of the three behav-
iors were: 1) lower perceived need for medications; 2) more medication affordability 
problems; 3) worse self-rated health; 4) diabetes or osteoporosis (relative to hyperten-
sion); and 5) younger age. Unique predictors of ‘forgot to take medications’ were 
higher concerns about the index medication and male gender. Unique predictors of 
‘run out of medications’ were non-white race, asthma, and higher number of total 
prescription medications. The unique predictor of ‘being careless’ was higher medica-
tion concerns. CONCLUSIONS: Unintentional non-adherence does not appear to be 
random and is predicted by medication beliefs, chronic disease, and sociodemograph-
ics. Interventions addressing unintentional non-adherence should not simply focus on 
reminders, but should also address medication beliefs related to perceived need, 
concerns, and medication affordability.
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PATIENTS USING SPECIALTY PHARMACIES FOR A TUMOR NECROSIS 
FACTOR ANTAGONIST HAD GREATER REFILL ADHERENCE THAN 
THOSE USING A RETAIL PHARMACIES
Liu Y1, Chao J2, Yang M2, Mulani P2
1University of Missouri-Kansas City, Kansas City, MO, USA, 2Abbott Laboratories, Abbott 
Park, IL, USA
OBJECTIVES: Retail pharmacies provide regular prescription drugs and some spe-
cialty prescription drugs, whereas specialty pharmacies focus on distributing specialty 
prescription drugs, including tumor necrosis factor (TNF) antagonists. It is unknown 
whether pharmacy type impacts patients’ adherence to anti-TNF therapy. We exam-
ined the relationship between pharmacy type (specialty vs. retail) and reﬁll adherence 
to the TNF antagonist adalimumab. METHODS: This was a retrospective analysis of 
prescription drug claims of patients in the United States using a TNF antagonist 
(adalimumab 40 mg/8-mL injection) during a dispensation period from January 2003 
to August 2009. Patients treated with adalimumab were included in the analysis 
regardless of diagnosis. For each patient, medication reﬁll adherence (MRA) was 
calculated as “total days of supply” divided by “total number of days evaluated,” 
multiplied by 100. A regression analysis was conducted, in which the dependent vari-
able was MRA and the independent variables included source of obtaining medication, 
reimbursement/payment type, total copayment/payment amount, age, sex, ethnicity, 
and annual income. RESULTS: Of the 86,943 patients included, 69% obtained the 
medication from a specialty pharmacy, 92% were members of Blue Cross and Blue 
Shield plans, 67% were women, and 81% were white. Average MRA was 84, and 
average age was 52 years. Signiﬁcant predictors (p < 0.05) of MRA included source 
where medication was obtained, reimbursement/payment type, total copayment/
payment amount, age, sex, and ethnicity; source where medication was obtained was 
the strongest predictor. MRA was 16% lesser for patients using a retail pharmacy vs. 
patients using a specialty pharmacy, controlling for the other independent variables. 
CONCLUSIONS: Patients using a specialty pharmacy to obtain a TNF antagonist had 
a greater reﬁll adherence than patients using a retail pharmacy. A specialty pharmacy 
usually provides services such as proactive reﬁll management and medication adher-
ence monitoring, which may improve patients’ adherence to therapy.
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STUDY THE IMPACT OF AUTOREFILL PROGRAM ON MEDICATION 
ADHERENCE
Jiang JZ, Khandelwal N, Frazee SG, Nadas J
Walgreens Co, Deerﬁeld, IL, USA
OBJECTIVES: To evaluate the impact of an automated prescription reﬁll intervention 
program on medication adherence. METHODS: A retrospective pre-post with case and 
control cohort study design was employed using a large administrative pharmacy claim 
database. An automated prescription reﬁll program was implemented in January 2009 
across ﬁve pharmacy stores. Patients who ﬁlled at least one maintenance medication 
during January of 2009 in either of ﬁve pre-identiﬁed test or ﬁve pre-identiﬁed control 
pharmacy retail stores were included in the test or control groups. Individual patients’ 
6-months pre and 6-months post adherence was compared by measuring mean Medica-
tion Possession Ratio (MPR). Relationship between Autoreﬁll program and medication 
adherence was investigated by linear regression models. RESULTS: A total of 14,904 
patient records from test group and 26,911 patient records from control group were 
identiﬁed and included in the study. Mean age for test group was higher than control 
group patients (60 vs 55). Both groups had similar gender distribution (Females-Test 
60.5% vs 60.4% control). Mean MPR for test group was found to be higher than 
control group (68% vs 60%). After controlling for demographic factors and pre-index 
MPRs, test group showed a signiﬁcant 4% increase in the mean MPR as compared to 
the control group patients (p < 0.05). Drill-down analyses were conducted across 
top ﬁve therapeutic classes including antihypertensives, antihyperlipicemics, antide-
pressants, contraceptives, and antidiabetics. Test group patients for all classes 
except antihypertensive and contraceptive agents reported signiﬁcantly higher mean 
MPR than control group patients (p < 0.05). Test patients using antihypertensive or 
contraceptive agents showed a higher mean MPR as compared to control group 
patients, however, those differences were not found to be statistically signiﬁcant. 
CONCLUSIONS: Study ﬁndings suggest that automated prescription reﬁll intervention 
program may have had a positive impact on patients’ adherence, especially in 
patients who were ﬁlling their antihyperlipidemic, antidepressant or antidiabetic 
medications.
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A SHORT 10-ITEM MEASURE OF COLLABORATIVE CLINICAL TEAM 
WORKING: THE WORKING IN HEALTH CARE QUESTIONNAIRE 
(WHQ-10)
Martin CR1, Redshaw M2
1University of the West of Scotland, Ayr, UK, 2University of Oxford, Oxford, UK
OBJECTIVES: Effective delivery of clinical care for women during pregnancy and the 
perinatal period is contingent on collaborative and supportive multidisciplinary team 
working. The current study reports the development of a short measure of effective 
and supportive team working within the context of maternity care services. The 
psychometric properties of the developed tool are decribed. METHODS: The tool was 
developed as an intrinsic component part of a staff survey reviewing maternity services 
in England, UK. Final item inclusion in the developed measure was determined by 
exploratory factor analysis (EFA) and conﬁrmatory factor analysis (CFA). Discrimi-
nate validity testing was conducted using analysis of variance (ANOVA) was used to 
determine discriminate validity using health worker classiﬁcation as the independent 
variable. RESULTS: A total of 1701 questionnaires selected by random sampling were 
subjected to EFA. Following maximum-likelihood extraction and oblimin rotation, 
two correlated factors were identiﬁed. These two sub-scales were labelled compliance 
and inﬂuence (4 items), and support and communication (6 items). The veracity of 
the factor structure and sub-scale differentiation was supported by CFA conducted on 
a further 1701 questionnaires. Discriminate validity was demonstrated on the total 
scale and both sub-scales (all p < 0.001). CONCLUSIONS: The 10-item Working in 
Healthcare Questionnaire (WHQ-10) is a valid and reliable self-report instrument that 
assesses the important dimensions of staff collaboration and cohesion. The sub-scales 
of the instrument are sensitive to staff structure and clinical discipline of the practi-
tioner and facilitates a useful measure to facilitate understanding of the dynamic 
processes of staff interaction within the clinical environment.
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IMPACT OF ENROLLING IN A CONSUMER-DRIVEN HEALTH PLAN 
(CDHP) ON MEDICATION ADHERENCE
Chen S
UnitedHealth Group, Hillsborough, NJ, USA
OBJECTIVES: To evaluate the impact of enrolling in a consumer-driven health plan 
(CDHP) on adherence to maintenance drugs. METHODS: Using a two-year (pre-year 
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and post-year) retrospective cohort design, adherence of patients who enrolled in 
traditional managed care plans in the pre-year but changed to full replacement CDHPs 
in the post-year was compared to that of patients who continuously enrolled in tra-
ditional plan. Adherence was measured in four ways: 1) post-year continuation rate, 
and among continuous users; 2) gap between the last reﬁll of the pre-year and the ﬁrst 
reﬁll in the post-year; 3) change of compliance rate from the pre- to the post-year; 
and 4) total days with continuous drug supply in the post-year. Analysis was con-
ducted on eight drug classes: asthma, cardiac, diabetes, epilepsy, hypertension, hyper-
lipidemia, rheumatoid arthritis, and thyroid, that were identiﬁed from Speciﬁc 
Therapeutic Classiﬁcation code. RESULTS: CDHP patients had a slightly higher 
illness burden and used more medication in the pre-year. Continuation rate in the 
post-year was relatively high for all drug classes though the CDHP patients were less 
likely continue for cardiac and cholesterol drugs. Among continuous patients, CDHP 
patients took slightly longer to reﬁll their ﬁrst prescription in the post-year for four 
drug classes (4 days longer for cardiac and hypertension drugs, 5 days longer for 
cholesterol and 3 days longer for thyroid drugs). Compliance rate dropped overtime 
in both cohorts but the reduction was bigger among CDHP patients for three drug 
classes (adjusted ratio of odds ratios was 0.77, 0.78, 0.69 for asthma, cardiac, and 
cholesterol drugs, respectively). CDHP patients also terminated their continuous drug 
supply earlier (21 days earlier for epilepsy and 27 days earlier cholesterol drugs, 
respectively). CONCLUSIONS: Adherence was lower in a few drug classes among 
patients who enrolled in consumer-driven health plans.
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MEDICATION USAGE BEHAVIOUR ASSESSMENT AMONGST 
OUTPATIENTS VISITING PUBLIC TEACHING HOSPITAL
Chawla S1, Dhanaraj E1, Tiwari P1, Thami G2
1National Institute of Pharmaceutical Education and Research, Mohali, Punjab, India, 
2Government Medical College and Hospital, Chandigarh, Chandigarh, India
OBJECTIVES: To assess the medication usage behaviour of prescription drugs and 
study self medication behaviour in outdoor patients. METHODS: A prospective 
observational study was performed in outpatient pharmacy at a public teaching 
hospital in Northern India. Patients more than 18 years and who could speak, write 
or read Hindi or English were included. Hearing and visually disabled patients were 
excluded. The medication usage behaviour, drug knowledge, adherence to prescribed 
medication and self medication behaviour were assessed using a structured and vali-
dated questionnaire using Cronbach Alpha. RESULTS: A total of 160 patients were 
assessed. The median age was 38 years. The most common problems identiﬁed 
involved awareness about the name and frequency of the drugs prescribed (39%), 
discontinuation of the medication without consultation (38%), unaware of proper 
storage of medicines (48%), knowledge about allergies (32%), and side effects (18%) 
of the drugs prescribed. Interestingly, it was observed that 90% of the patients had 
an understanding of their disease(s) diagnosed. Patients maintained regular follow up 
with the physician (88%) and consulted physician/pharmacist in case of an unpleasant/ 
alarming drug effect (77%). Majority of the patients (61%) used ayurvedic/homeo-
pathic preparations in conjunction with prescribed allopathic medicines. More than 
three fourths of the patients (82%) self medicated using herbals and other dietary 
supplements for their illness. OTC medication use (85%) was seen for common indica-
tions such as fever, cough, headache and bodyache. CONCLUSIONS: Based upon 
these ﬁndings, it is clear that improvement in medication usage behaviour requires 
counseling to the patients in the identiﬁed areas.
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ASSESSMENT OF PHARMACOECONOMIC EVALUATIONS SUBMITTED 
FOR REIMBURSEMENT SINCE KOREAN POSITIVE LIST SYSTEM 
INTRODUCTION
Yim EY, Park SE, Oh MJ, Kim DW, Park HK, Gong JR, Kim KH, Lim SH, Yi SY
Health Insurance Review and Assessment service, Seoul, Seoul, South Korea
OBJECTIVES: We assessed the quality and characteristics of pharmacoeconomic 
evaluation submitted for reimbursement since Korean positive list system introduction. 
METHODS: Twenty-four submissions with pharmacoeconomic evaluation (PE) were 
included in this study, which are new medicines evaluated by Drug Beneﬁt Coverage 
Assessment Committee (DBCAC) from introduction of positive list system to June 30th 
in 2009. We evaluated them with HIRA PE checklist consisted of 21 items which 
was developed for assessing the appropriateness according to the guideline of phar-
macoeconomic evaluation in Korea and QHES checklist. RESULTS: Twenty-four 
submissions were categorized as Cost-Minimization analysis (n = 16, 66.6%), Cost-
Effectiveness analysis (n = 4, 16.7%) and Cost-Utility analysis (n = 4, 16.7%). On the 
average, 15 among 21 items of HIRA PE checklist were fulﬁlled (73%, range 
52.4∼100%) and quality assessment score by QHES was 62.1 (range 31–97). The 
items which submissions mostly followed were presenting analysis perspective, disag-
gregated incremental cost-effectiveness ratio, appropriate selection of primary 
outcome and discount rate of cost and effectiveness. The issues noted as inadequate 
submissions were obscure search process of cost and effectiveness data, cost estima-
tion, insufﬁcient examination of uncertainty and generalizability. The range of ICER 
per QALY (n = 4) was showed from 8K to 59K USD. DBCAC didn’t evaluate cost-
effectiveness with explicit threshold values and decisions considering ICER were made 
by deliberating on the uncertainty surrounding them as well as disease severity, societal 
burden, quality of life, and innovative nature of the medicine. CONCLUSIONS: This 
study could be helpful for understanding present state of pharmacoeconomic evalua-
tion submitted since the introduction of Korean positive list system and valuable for 
suggesting items required to be improved for appraisal.
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PHARMACY BENEFIT INTEGRATION AND ADHERENCE TO EVIDENCE-
BASED MEDICINE IN A COMMERCIALLY-INSURED POPULATION
Bunz TJ, Nguyen HV
CIGNA, Bloomﬁeld, CT, USA
OBJECTIVES: The purpose of this analysis was to determine if integration of phar-
macy beneﬁts had an impact on the number of gaps in evidence-based care experienced 
by individuals and the number of gaps in care that those individuals close. METHODS: 
Database analysis was conducted on 262,000 individuals with coverage in 2008. 
Participants had to have 12 months of continuous enrollment in order to be included 
in the analysis. Matching on age, gender, and health risk was completed to partially 
adjust for differences between integrated and carve-out employers. A two-part regres-
sion model was then used to identify differences in the likelihood that individuals 
would adhere to evidence-based standards, and in the number of gaps in care that 
they would experience, while controlling for additional factors such as participation 
in outreach programs and plan design. RESULTS: Participants with integrated phar-
macy beneﬁts had a higher rate of gaps in care (Odds ratio 1.04, 95% ci 1.014–1.064), 
although the numbers of gaps experienced were lower (4.78 [95% ci 4.77–4.81] vs. 
4.87 [95% ci 4.85–4.89] in integrated plans vs. carve-out). While controlling for the 
initial number of open gaps, the likelihood of gap closure was higher in integrated 
plans than in carve-outs (Odds ratio 1.028 [95% ci 1.003–1.054]). The number of 
gaps closed was also higher (2.13 [95% ci 2.13–2.13] vs. 2.01 [95% ci 2.01–2.01] in 
integrated vs. carve-out). CONCLUSIONS: Higher rates of evidence-based gap closure 
are associated with individuals that participate in health plans with integrated phar-
macy beneﬁts when compared to individuals with carved-out plans.
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RATIONAL USE EFFECTS OF IMPLEMENTING AN ESSENTIAL 
MEDICINES LIST
Younis MZ1, Hamidi S2, Forgione D3, Hartmann M4
1Jackson state University, New Orleans, LA, USA, 2Hamadan Bin Mohammad University, 
Dubai, Dubai, United Arab Emirates, 3University of Texas at San Antonio, San Antonio, TX, 
USA, 4Friedrich Schiller University of Jena, Jena, Germany
OBJECTIVES: Develop an essential medicines list (EML) in 2000 to improve rational 
use of medicines and contain costs in Middle East- Palestine. METHODS: We exam-
ined effects of the EML in the Palestinian health care public sector. We obtained data 
on prescription patterns for medicines from 3570 prescriptions given during outpatient 
visits in 17 health care facilities in the West Bank from 1997 to 2003. We analyzed 
the prescriptions to measure rational use. We modeled indicators of rational use as a 
function of the EML and 16 health center indicator variables. RESULTS: The 
EML was effective in shifting all prescribing indicators toward standard values. To 
improve rational medicine use, treatment protocols for the most common diseases and 
continuous education for medical staff is required. CONCLUSIONS: Treatment pro-
tocols that limit physicians’ prescription choices for the most common diseases are 
necessary to improve the rational use of medicines in any setting. We found that the 
prescribing indicators least affected were the number of medicines per encounter and 
antibiotics as a percent of all medicines prescribed. The most affected indicator was 
the injectable medicines as a percent of all prescribed medicines. While change in the 
use of injectable medicines may be related to changes in individual preferences, cultural 
beliefs and values, most of the patients were aware of the implementation of EML, 
since their medicines where changed and substituted with less expensive bioequivalent 
ones.
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WILLINGNESS TO PAY FOR PHARMACY SERVICES: A REVIEW
Painter JT, Blumenschein K
University of Kentucky, Lexington, KY, USA
BACKGROUND: Quantifying the value of pharmacist-provided services beyond dis-
pensing is imperative for the profession of pharmacy as it works to establish a baili-
wick within the evolving health care system. To date, the preponderance of research 
assessing the value of pharmacist-provided services takes a health care payer’s perspec-
tive. Less is known about the value consumers place on these services. The contingent 
valuation, or willingness-to-pay, method has been proposed as a technique to obtain 
consumer valuation of pharmacist-provided services. OBJECTIVES: The purpose of 
this research is to identify all published studies using the contingent valuation method 
to value pharmacist-provided services and evaluate those studies against published 
criteria for conducing contingent valuation surveys. METHODS: Relevant studies 
published in the English language were identiﬁed searching MEDLINE, ECONLIT 
and International Pharmaceutical Abstracts databases through December, 2008. Only 
studies that speciﬁcally elicited willingness-to-pay from actual or potential consumers 
of community pharmacist provided services were included. RESULTS: Twenty-three 
studies were identiﬁed using the search strategy outlined. Eighteen pharmacist-pro-
vided services were assessed in a variety of demographic and geographic populations. 
Studies were appraised using the 1993 NOAA panel recommendations for the contin-
gent valuation method. Not surprisingly, studies published before 1999 tended to use 
less standardized methods and typically did not conform to NOAA panel recommen-
dations, whereas those published after 1999 tended to have greater methodologic and 
statistical rigor. CONCLUSIONS: Surprisingly few published studies have employed 
the contingent valuation method to assess consumers’ perceptions of pharmacist-
provided services. Improving the quantity and quality of such studies will aid the 
profession in marketing pharmacy services to consumers. Understanding the pharmacy 
services that consumer’s value and their willingness-to-pay for those services will be 
